Clinical Trial Update: Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.

View source ↗

Summary

This clinical trial update describes the evaluation of tucatinib in patients with locally advanced or metastatic HER2-positive breast cancer who have received a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tucatinib (tucatinib)

Snippet

Sponsor: iOMEDICO AG | Conditions: HER2-positive Breast Cancer | Status: COMPLETED